Vimta Labs Reports Record Q2 FY26 Revenue at ₹104.5 Crore, Up 22.3% YoY

Hyderabad, November 3, 2025 – Vimta Labs Limited (NSE: VIMTALABS | BSE: 524394) made a regulatory filing in which it announced its financial results for the quarter ended September 2025. The company has set a new benchmark with it solid financial performance during the quarter. It achieved its highest-ever quarterly revenue in the quarter. The outcome was mainly due to strong performance in its pharmaceutical and food testing services.

Financial Performance Overview

For the Q2FY26, the company reported total income of ₹104.5 crore which is an up of 22.3% on year-on-year basis. During the quarter the EBITDA also jumped by 20.6% to ₹36.9 crore. Further, the profit after tax of the company climbed 17.1% reaching ₹19.9 crore. The margins of the company were also steady for the period at a solid19.1%, while the EPS moved up 18.4% to ₹4.5. All in all, the company continues to grow quarter after quarter.

As the second quarter end was also the end of the first half of the financial year, the company’s half-yearly performance was also reviewed. The total income increased to ₹203.8 crore, up 26.6% during the half-year, while the profit after tax also jumped 25.6% to ₹38.8 crore. The company’s EBITDA has also risen significantly, up 26.4% to ₹72.3 crore, while margins held steady at 35.5%.

What Management Has to Say

Expressing enthusiasm towards the positive results, Managing Director of the company, Harita Vasireddi, stated, “Vimta Labs had a successful quarter with our highest-ever revenue of approximately ₹104 crore. The growth was driven by robust demand across pharmaceutical research and testing as well as food testing services, with stable performance in other verticals.” She further added that the company has cleared a WHO audit of its clinical research activities. She acknowledged it as a landmark, as it re-establishes that the company maintains quality and adheres to standards.

Stock Market Snapshot

As of November 3, 2025, the share of Vimta Labs Limited closed at ₹680, down 45.40 or 6.26% from its previous close of ₹725.40. The share opened at ₹727.40 and tarded between ₹735 and ₹672, high and low, with a market cap of 3,231 Cr.

REF: https://nsearchives.nseindia.com/corporate/VIMTALABS_03112025143936_Reg_30.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations